Matarin Capital Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-3,096
| Closed | -$348K | – | 327 |
|
|
2018
Q1 | $348K | Hold |
3,096
| – | – | 0.03% | 265 |
|
|
2017
Q4 | $458K | Hold |
3,096
| – | – | 0.04% | 255 |
|
|
2017
Q3 | $363K | Hold |
3,096
| – | – | 0.03% | 255 |
|
|
2017
Q2 | $402K | Hold |
3,096
| – | – | 0.04% | 233 |
|
|
2017
Q1 | $419K | Hold |
3,096
| – | – | 0.04% | 232 |
|
|
2016
Q4 | $444K | Hold |
3,096
| – | – | 0.05% | 205 |
|
|
2016
Q3 | $366K | Hold |
3,096
| – | – | 0.04% | 204 |
|
|
2016
Q2 | $328K | Sell |
3,096
-26,206
| -89% | -$2.78M | 0.04% | 214 |
|
|
2016
Q1 | $3.27M | Buy |
29,302
+2,776
| +10% | +$309K | 0.46% | 95 |
|
|
2015
Q4 | $4.15M | Buy |
26,526
+3,136
| +13% | +$491K | 0.62% | 73 |
|
|
2015
Q3 | $3.07M | Buy |
23,390
+5,806
| +33% | +$762K | 0.63% | 71 |
|
|
2015
Q2 | $3.06M | Buy |
17,584
+832
| +5% | +$145K | 0.88% | 32 |
|
|
2015
Q1 | $2.89M | Buy |
16,752
+921
| +6% | +$159K | 0.88% | 28 |
|
|
2014
Q4 | $2.05M | Sell |
15,831
-6,516
| -29% | -$844K | 0.9% | 36 |
|
|
2014
Q3 | $2.87M | Sell |
22,347
-418
| -2% | -$53.8K | 1.32% | 4 |
|
|
2014
Q2 | $2.01M | Buy |
22,765
+3,701
| +19% | +$328K | 0.9% | 37 |
|
|
2014
Q1 | $1.79M | Sell |
19,064
-2,531
| -12% | -$238K | 1.06% | 23 |
|
|
2013
Q4 | $2.44M | Buy |
21,595
+6,305
| +41% | +$713K | 1.5% | 9 |
|
|
2013
Q3 | $1.21M | Buy |
15,290
+2,531
| +20% | +$200K | 1.01% | 28 |
|
|
2013
Q2 | $840K | Buy |
+12,759
| New | +$840K | 0.85% | 41 |
|